Putin hails health ministry as Russia approves COVID-19 vaccine, Sputnik V

President Vladimir Putin said on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move Moscow likened to its success in the Cold War-era space race, Reuters reports.

The COVID-19 vaccine, which will be called “Sputnik V” in homage to the world’s first satellite launched by the Soviet Union, has however not yet completed its final trials.

Moscow’s decision to grant approval before then has raised concerns among some experts. Only about 10% of clinical trials are successful and some scientists fear Moscow may be putting national prestige before safety.

Putin and other officials have said it is completely safe. The president said one of his daughters had taken it as a volunteer and felt good afterwards.

“I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the necessary checks,” Putin told a government meeting.

The Russian business conglomerate Sistema has said it expects to put the vaccine, developed by Moscow’s Gamaleya Institute, into mass production by the end of the year.

Government officials have said it will be administered to medical personnel, and then to teachers, on a voluntary basis at the end of this month or in early September. Mass roll-out in Russia is expected to start in October.

The vaccine is administered in two doses and consists of two serotypes of a human adenovirus, each carrying an S-antigen of the new coronavirus, which enter human cells and produce an immune response.

The platform used for the vaccine was developed by Russian scientists over two decades and had formed the basis for several vaccines in the past, including those against Ebola.

Authorities hope it will allow the Russian economy, which has been battered by fallout from the virus, to return to full capacity.

Kirill Dmitriev, head of Russia’s sovereign wealth fund, said Russia had already received foreign requests for 1 billion doses. He said the vaccine also expected to be produced in Brazil.

Dmitriev said clinical trials were expected to start soon in the United Arab Emirates and the Philippines. Philippine President Rodrigo Duterte has said he is willing to participate personally.

PHASE III TRIAL
The approval by the health ministry comes before the start of a larger trial involving thousands of participants, commonly known as a Phase III trial.

Such trials, which require a certain proportion of participants to catch the virus to observe the vaccine’s effect, are normally considered essential precursors for a vaccine to receive regulatory approval.

The Moscow-based Association of Clinical Trials Organizations (ACTO), a trade body representing the world’s top drugmakers in Russia, this week urged the ministry to postpone approval until that final trial had been successfully completed.

In a letter to the ministry, it said there were high risks associated with registering a drug before that happened.

“It is during this phase that the main evidence of a vaccine’s efficacy is collected, as well as information on adverse reactions that could appear in certain groups of patients: people with weakened immunity, people with concomitant diseases and so forth,” it said.

Some international experts have also questioned the speed at which Russia approved its vaccine.

“Normally you need a large number of people to be tested before you approve a vaccine,” said Peter Kremsner from the University Hospital in Tuebingen, Germany, currently testing CureVac’s COVID-19 vaccine in clinical trials.

“In that respect, I think it’s reckless to do that (approve it) if lots of people haven’t already been tested.”

U.S. Health Secretary Alex Azar, asked about Russia’s announcement, said safety was paramount and late-stage trials were key. He said the United States was on track for an effective vaccine by the end of the year, with six candidates under development.

“The point is not to be first with a vaccine. The point is to have a vaccine that is safe and effective,” Azar said on ABC News’ “Good Morning America” programme.

“We hope it’s true, but as is so often the case with Russia: trust but verify,” White House Council of Economic Advisers Acting Chairman Tyler Goodspeed said on Fox Business Network, referencing a Russian proverb cited by former U.S. president Ronald Reagan in negotiations with the Kremlin.

More than 100 possible COVID-19 vaccines are being developed around the world. At least four are in final Phase III human trials, according to WHO data.

 

YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE

COVID-19: FG directs civil servants on levels 12, 13 to resume
The Federal Government has directed civil servants on Grade Levels 12 and 13 to return to work immediately. The Head of the Civil Service of the Federation (HoSCF), Dr Folashade Yemi-Esan, gave the directive in a circular dated August 10, 2020, where she similarly directed those on essential duties to resume full duties. Since the initial lockdown measures over the COVID-19 pandemic, only workers on Grade Level 14 and above had been allowed to work…

UPDATE: Why Boko Haram recruit more members ― North-East governors
Following the recent attack on the convoy of Governor Babagana Zulum of Borno State, six governors of the northeast states and heads of security agencies have met with President Muhammadu Buhari at the presidential villa, Abuja, with the state chief executives disclosing that insurgents are able to recruit more followers because of lack of access to farmlands…

Deregistration of political parties: INEC approaches Supreme Court
The Independent National Electoral Commission (INEC) last night gave an indication that it would approach the apex court to set aside the judgment of the appeal court which overruled it on the delisting of political parties. The electoral umpire had delisted 77 political parties after the 2019 general elections. It premised its action on the failure of the parties to win a single seat in the last elections…

ASUU set to present alternate salary payment platform to FG
After months of opposition to the implementation of the Integrated Payment and Personnel Information System (IPPIS), the Academic Staff Union of Universities (ASUU) is set to make an initial presentation of its own platform known as University Transparency and Accountability Solution (UTAS) to the Federal Government…